Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 1, 2026 · Leadership change · Investor press release · Financial statements
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
7
Leadership change
Jun 1, 2026
| Item 5.02 | Director or executive officer departure or appointment |
| Item 7.01 | Regulation FD disclosure (investor press release or presentation) |
| Item 9.01 | Financial statements and exhibits |
LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift.
1 LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors Bringing More Than Three Decades of Energy Investment Experience, Mr.
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
